It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"I want to put an end to the game playing.”
A new trove of emails shows President Barack Obama’s White House agreed to help drug companies block a proposal to bring down medicine prices so they would back Obama’s healthcare plan.
www.newsmax.com...
On June 3, 2009, one of the lobbyists e-mailed Nancy-Ann DeParle, the president’s health care adviser.
Ms. DeParle reassured the lobbyist. Although Mr. Obama was overseas, she wrote, she and other top officials had “made decision, based on how constructive you guys have been, to oppose importation” on a different proposal. ...
Just like that, Mr. Obama’s staff signaled a willingness to put aside support for the
reimportation of prescription medicines at lower prices and by doing so solidified a compact
with an industry the president had vilified on the campaign trail. Central to Mr. Obama’s drive to
remake the nation’s health care system was an unlikely collaboration with the pharmaceutical
industry that forced unappealing trade-offs. www.nytimes.com...
“That’s an example of the same old game playing in Washington.
You know, I don’t want to learn how to play the game better.
Drugmakers led by Pfizer (PFE) Inc. agreed to run a “very significant public campaign” bankrolling political support for the 2010 health-care law, including TV ads, while the Obama administration promised to block provisions opposed by drugmakers, documents released by Republicans show.
The internal memos and e-mails for the first time unveil the industry's plan to finance positive TV ads and supportive groups, along with providing $80 billion in discounts and taxes that were included in the law. The administration has previously denied the existence of a deal involving political support.
The documents were released today by Republicans on the House Energy and Commerce Committee. They identify price controls under Medicare and drug importation as the key industry concerns, and show that former Pfizer Chief Executive Officer Jeffrey Kindler and his top aides were involved in drawing it up and getting support from other company executives.
“President Obama’s efforts to enlist the support of private industry are exactly what presidents have always done to enact major legislation,” U.S. Representatives Henry Waxman of California and Diana DeGette of Colorado said in a joint statement.
Waxman and DeGette, in their statement, said the Democrats had managed to get more than the $80 billion out of drugmakers described in the memos, putting the figure at $110 billion to $125 billion.
Included in the documents released by the Republicans was an October 2012 e-mail from Bryant Hall, a PhRMA lobbyist,
In it, Hall wrote that the Obama administration had agreed to block a proposal by Democrats in Congress that would let people import pharmaceutical products from outside the U.S., where price controls offer them at lower costs than they can be obtained inside the U.S.
The White House “is working on some very explicit language to kill it in health-care reform,” Hall wrote in an e-mail sent to Kindler and Sally Susman, a current Pfizer executive vice president and head of the New York-based drugmaker’s public policy and communications operations.
[/end quote from older thread]
post by jdub297 (posted on May-31-2012)
It's not as if PhRMA just walked in an offered to help. Duplicitous, Chicago-thug as always, Obama was bad-mouthing big pharmaceuticals in public, while pressuring them in private to "play ball," or else.
The Obama administration aggressively pursued the pharmaceutical industry to make a deal in support of health care reform legislation in mid-2009, according to a series of emails released Thursday by Republicans on the House Energy and Commerce Committee.
In particular, pharmaceutical industry executives' correspondence confirmed that White House officials agreed to “kill” efforts on Capitol Hill to allow drugs to be imported from other countries — one of the chief legislative priorities of the industry — to get the industry’s backing.
W.H. pushed hard for PhRMA health reform deal
Right now, the last thing the W.H. wants to have exposed is that what they were telling the public to sell the Bill was not what they were cobbling together to get what they wanted.
In one email exchange obtained by the committee, a pharmaceutical executive said that then-White House spokesman Robert Gibbs had suggested he would publicly call out PhRMA if it didn’t sign to the deal. Another exchange says the White House threatened to use the president’s radio address to call for rebates for prescription drugs in all of Medicare Part D, a proposition the drug industry strongly opposed.
Reimportation of prescription drugs, an issue that the pharmaceutical industry has repeatedly opposed, played a strong role in the negotiations. While the issue has come up for votes on Capitol Hill numerous times over several years and never become law, the industry has always worried that it will.
Nancy-Ann DeParle, who then led the White House Office of Health Reform, said in one email to a pharmaceutical industry executive that she favored the reimportation policy but agreed to stop pursuing it because the industry was being so constructive on health reform.
“I pushed this,” she wrote to a PhRMA lobbyist, “but [Phil Schiliro, Dana Singiser] and I made [the] decision, based on how constructive you guys have been, to oppose importation on this bill.” She was referring to top White House legislative affairs officials.
www.politico.com...
Here's an email where a WH staffer appears to be quite pleased with the "help" they are providing PhRMA in exchange for support:
Courtesy of The Washington Examiner
Details of secret PhRMA deal reveal Obama's hypocrisy
Of course, the Obama campaign is "shocked, I tell you, shocked." Not tht this happened, but that it would come out during the campaign:
White House spokesman Eric Schultz dubbed the investigation “a nakedly political, taxpayer-funded crusade to hurt the president’s reelection campaign.”
“This is the same House committee that has spent, according to one report, over $1 million in taxpayer dollars for the past 15 months looking into baseless allegations on Solyndra — but has done almost nothing to move legislation that would create jobs or grow the economy,” he said.
W.H. pushed hard for PhRMA health reform deal
Who would've guessed?
jw
Originally posted by beezzer
Could this account for the drug shortage also?
ie; Create a problem, then offer a solution?
Originally posted by beezzer
reply to post by xuenchen
Forget Fast & Furious, this could be huge!
This is career ending.
Mr. Obama’s deal-making in 2009 represented a pivotal moment in his young presidency, a juncture where the heady idealism of the campaign trail collided with the messy reality of Washington policy making. A president who had promised to negotiate on C-Span cut a closed-door deal with a powerful lobby, signifying to disillusioned liberal supporters a loss of innocence, or perhaps even the triumph of cynicism.
Originally posted by METACOMET
The point of healthcare law "Obamacare" is to give the big insurance companies a monopoly so they can give you crap care with no competition. "Free healthcare" is a lie. How people can think Obamacare is a good thing is beyond me.
Originally posted by xuenchen
The video proves that the promises he keeps are usually small time chicken feed and pigeon splats.
Originally posted by xuenchen
Bloomberg Story
By Drew Armstrong - May 31, 2012
url=http://www.bloomberg.com/news/2012-05-31/drugmakers-vowed-to-campaign-for-health-law-memos-show.html
...
Drugmakers led by Pfizer (PFE) Inc. agreed to run a “very significant public campaign” bankrolling political support for the 2010 health-care law, including TV ads, while the Obama administration promised to block provisions opposed by drugmakers, documents released by Republicans show.
The internal memos and e-mails for the first time unveil the industry's plan to finance positive TV ads and supportive groups, along with providing $80 billion in discounts and taxes that were included in the law. The administration has previously denied the existence of a deal involving political support.
The documents were released today by Republicans on the House Energy and Commerce Committee. They identify price controls under Medicare and drug importation as the key industry concerns, and show that former Pfizer Chief Executive Officer Jeffrey Kindler and his top aides were involved in drawing it up and getting support from other company executives.
“I pushed this,” she wrote to a PhRMA lobbyist, “but [Phil Schiliro, Dana Singiser] and I made [the] decision, based on how constructive you guys have been, to oppose importation on this bill.” She was referring to top White House legislative affairs officials.
www.politico.com...